4/A: W.K. Kellogg Foundation Trust Amends Kellanova Stock Sale Price

The W.K. Kellogg Foundation Trust filed an amended Form 4 to correct the average sale price of 114,583 Kellanova common shares sold on July 21, 2025, to $79.8697.

Summary

• An amendment to a Form 4 was filed by the W.K. Kellogg Foundation Trust and W.K. Kellogg Foundation, a 10% owner and director of Kellanova.
• The amendment corrects an administrative error in the average sale price of Kellanova common stock.
• 114,583 shares of common stock were sold on July 21, 2025.
• The corrected average sale price for the transaction is $79.8697, adjusted from the originally reported $79.92.
• Following the reported transaction, the W.K. Kellogg Foundation Trust beneficially owns 45,670,369 shares of Kellanova common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, with instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024.

Sentiment

Score: 5

Explanation: Neutral. This is an administrative correction of a previously reported insider sale. It does not convey new positive or negative information about the company's operations or financial health beyond the fact of a planned insider sale.

Future Outlook

No future outlook or guidance is provided in this administrative filing.

Industry Context

This filing is an administrative amendment to an insider transaction report and does not provide broader industry context or trends.

Related Party Transactions

• The sale of shares by the W.K. Kellogg Foundation Trust, a 10% owner and entity with a director relationship to Kellanova, constitutes a related party transaction, routinely disclosed in Form 4 filings.

Stakeholder Impact

• Minimal direct impact on shareholders beyond the routine disclosure of a large shareholder's pre-planned sale and the correction of an administrative detail.

Key Dates

Recommendation

This filing is an administrative amendment to correct a minor detail of a previously disclosed insider sale. It provides no new fundamental information about Kellanova's business operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The sale itself was pre-planned under a 10b5-1 plan, indicating it was not based on new material non-public information. Therefore, a 'hold' recommendation remains appropriate as this filing does not alter the investment thesis.

Keywords

Kellanova, K, W.K. Kellogg Foundation Trust, Insider Sale, Form 4/A, SEC Filing, Equity Transaction, 10b5-1 Plan, Common Stock